23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A Neuron-Optimized CRISPR/dCas9 Activation System for Robust and Specific Gene Regulation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          CRISPR-based technology has provided new avenues to interrogate gene function, but difficulties in transgene expression in post-mitotic neurons has delayed incorporation of these tools in the central nervous system (CNS). Here, we demonstrate a highly efficient, neuron-optimized dual lentiviral CRISPR-based transcriptional activation (CRISPRa) system capable of robust, modular, and tunable gene induction and multiplexed gene regulation across several primary rodent neuron culture systems. CRISPRa targeting unique promoters in the complex multi-transcript gene brain-derived neurotrophic factor ( Bdnf) revealed both transcript- and genome-level selectivity of this approach, in addition to highlighting downstream transcriptional and physiological consequences of Bdnf regulation. Finally, we illustrate that CRISPRa is highly efficient in vivo, resulting in increased protein levels of a target gene in diverse brain structures. Taken together, these results demonstrate that CRISPRa is an efficient and selective method to study gene expression programs in brain health and disease.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: found
          • Article: not found

          CRISPR RNA-guided activation of endogenous human genes

          Catalytically inactive CRISPR-associated 9 nuclease (dCas9) can be directed by short guide RNAs (gRNAs) to repress endogenous genes in bacteria and human cells. Here we show that a dCas9-VP64 transcriptional activation domain fusion protein can be directed by single or multiple gRNAs to increase expression of specific endogenous human genes. These results provide an important proof-of-principle that CRISPR-Cas systems can be used to target heterologous effector domains in human cells.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Editing DNA Methylation in the Mammalian Genome.

            Mammalian DNA methylation is a critical epigenetic mechanism orchestrating gene expression networks in many biological processes. However, investigation of the functions of specific methylation events remains challenging. Here, we demonstrate that fusion of Tet1 or Dnmt3a with a catalytically inactive Cas9 (dCas9) enables targeted DNA methylation editing. Targeting of the dCas9-Tet1 or -Dnmt3a fusion protein to methylated or unmethylated promoter sequences caused activation or silencing, respectively, of an endogenous reporter. Targeted demethylation of the BDNF promoter IV or the MyoD distal enhancer by dCas9-Tet1 induced BDNF expression in post-mitotic neurons or activated MyoD facilitating reprogramming of fibroblasts into myoblasts, respectively. Targeted de novo methylation of a CTCF loop anchor site by dCas9-Dnmt3a blocked CTCF binding and interfered with DNA looping, causing altered gene expression in the neighboring loop. Finally, we show that these tools can edit DNA methylation in mice, demonstrating their wide utility for functional studies of epigenetic regulation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9.

              Probing gene function in the mammalian brain can be greatly assisted with methods to manipulate the genome of neurons in vivo. The clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated endonuclease (Cas)9 from Streptococcus pyogenes (SpCas9) can be used to edit single or multiple genes in replicating eukaryotic cells, resulting in frame-shifting insertion/deletion (indel) mutations and subsequent protein depletion. Here, we delivered SpCas9 and guide RNAs using adeno-associated viral (AAV) vectors to target single (Mecp2) as well as multiple genes (Dnmt1, Dnmt3a and Dnmt3b) in the adult mouse brain in vivo. We characterized the effects of genome modifications in postmitotic neurons using biochemical, genetic, electrophysiological and behavioral readouts. Our results demonstrate that AAV-mediated SpCas9 genome editing can enable reverse genetic studies of gene function in the brain.
                Bookmark

                Author and article information

                Journal
                eNeuro
                eNeuro
                eneuro
                eneuro
                eNeuro
                eNeuro
                Society for Neuroscience
                2373-2822
                25 February 2019
                7 March 2019
                Jan-Feb 2019
                : 6
                : 1
                : ENEURO.0495-18.2019
                Affiliations
                [1 ]Department of Neurobiology and Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham , Birmingham, AL, 35294
                [2 ]Civitan International Research Center, University of Alabama at Birmingham , Birmingham, AL, 35294
                Author notes

                The authors declare no competing financial interests.

                Author contributions: K.E.S., S.V.B., M.E.Z., J.S.R., N.A.G., J.J.T., C.G.D., F.A.S., J.N.B., D.W., L.I., and J.J.D. designed research; K.E.S., S.V.B., M.E.Z., J.S.R., N.A.G., J.J.T., C.G.D., F.A.S., J.N.B., D.W., L.I., and J.J.D. performed research; K.E.S., S.V.B., M.E.Z., J.S.R., N.A.G., J.J.T., C.G.D., F.A.S., J.N.B., D.W., L.I., and J.J.D. analyzed data; K.E.S., S.V.B., and J.J.D. wrote the paper.

                This work was supported by National Institutes of Health Grants DA039650, DA034681, and MH114990 (to J.J.D.), DA042514 (to K.E.S.), MH112304 (to S.V.B.), and DA041778 (to F.A.S.). L.I. is supported by the Civitan International Research Center at University of Alabama at Birmingham (UAB). Additional assistance to J.J.D. was provided by the UAB Pittman Scholars Program.

                [^]

                K.E.S. and S.V.B. contributed equally to this work.

                Correspondence should be addressed to Jeremy J. Day at jjday@ 123456uab.edu .
                Author information
                http://orcid.org/0000-0003-1102-9549
                http://orcid.org/0000-0002-7361-3399
                Article
                eN-MNT-0495-18
                10.1523/ENEURO.0495-18.2019
                6412672
                30863790
                b7b653cb-97be-405e-a939-a240b0f54338
                Copyright © 2019 Savell et al.

                This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

                History
                : 18 December 2018
                : 21 January 2019
                : 27 January 2019
                Page count
                Figures: 8, Tables: 0, Equations: 0, References: 65, Pages: 17, Words: 13254
                Funding
                Funded by: http://doi.org/10.13039/100000026HHS | NIH | National Institute on Drug Abuse (NIDA)
                Award ID: DA039650
                Award ID: DA042514
                Award ID: DA041778
                Funded by: http://doi.org/10.13039/100000025HHS | NIH | National Institute of Mental Health (NIMH)
                Award ID: MH14990
                Award ID: MH112304
                Categories
                7
                7.2
                Methods/New Tools
                Novel Tools and Methods
                Custom metadata
                January/February 2019

                bdnf,crispr,epigenetics,gene expression,transcription
                bdnf, crispr, epigenetics, gene expression, transcription

                Comments

                Comment on this article